pharma · Hypercholesterolemia · Hyperlipidemia · ESPR
Esperion Therapeutics
Esperion Therapeutics patent portfolio — 55 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Ann Arbor, US
- Employees
- 5
- Programs
- 15
- Drugs
- 9
- Patents
- 55
Esperion Therapeutics patents
55 pharmaceutical patents indexed for Esperion Therapeutics. 4 expire within 24 months.
Esperion Therapeutics has 55 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6506879
Purified Apo A and Apo E compounds and methods for using them
expired -
US 6459003
Ether compounds
expired -
US 6410802
Methods for synthesizing ether compounds and intermediates therefor
expired -
US 6376464
Lipid complexes of APO A-1 agonist compounds
expired -
US 6367479
METHOD OF FORCING THE REVERSE TRANSPORT OF CHOLESTEROL FROM A BODY PART TO THE LIVER WHILE AVOIDING HARMFUL DISRUPTIONS OF HEPATIC CHOLESTEROL HOMEOSTASIS, AND PHARMACEUTICAL COMPOSITIONS AND KIT RELATED THERETO
expired -
US 6329341
Method of treating septic shock
expired -
US 6287590
Peptide/lipid complex formation by co-lyophilization
expired
Frequently asked questions
How many patents does Esperion Therapeutics have?
55 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Esperion Therapeutics patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.